暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股期权个股详情
SNY240517P47500
- 0.31
- 0.000.00%
延时15分钟行情收盘价 05/17 09:39 (美东)
0.31最高价0.31最低价
0.31今开0.31昨收9张成交量236张未平仓合约数47.50行权价0.00成交额479.55%隐含波动率-2.54%溢价2024/05/17到期日0.00内在价值100合约乘数-2天距到期日0.31时间价值100合约规模美式期权类型-0.2618Delta0.1699Gamma156.19杠杆倍数-12.8744Theta0.0000Rho-40.89有效杠杆0.0013Vega
分时
- 5日
- 日K
新闻
赛诺菲：有关投票权和股份总数的信息-2024年4月
Regeneron、赛诺菲公布肺部疾病候选治疗的阳性结果
Regeneron Pharmicals（REGN）和赛诺菲（SNY）周一表示，其肺部疾病治疗药物Dupixent的3期试验是针对慢性阻塞性不受控制的成人的附加维持疗法
Regeneron Pharmicals和赛诺菲公布了使用Dupixent的NOTUS确认性3期慢性阻塞性肺病试验的最新数据；在ATS上发表并发表在《新英格兰医学杂志》上
NOTUS的结果证实了BOREAS三期试验的里程碑数据，并显示与安慰剂相比，在不受控制的慢性患者中，Dupixent显著减少了34％的恶化并改善了肺功能
快讯 | 赛诺菲交易后，对冲基金Shah Capital结束了针对公司董事会的竞选活动，Novavax股价上涨了1.2％
快讯 | Shah Capital：相信Novavax最近与赛诺菲签订的许可协议是 “朝着正确方向迈出的一步” ——美国证券交易委员会备案
由于Dupixent的扩张和管道潜力，赛诺菲获得强劲的买入评级
评论
$赛诺菲安万特(SNY.US$
Alright, folks, let’s dive into the world of biotech drama. Shares of Novavax (NVAX) have been on a tear, continuing their climb on Monday after the company dropped some major news last week. They announced a licensing deal with Sanofi, and the stock shot up 47.6%, closing at $13.11. That's the highest it's been since December 2022.
But wait, there's more! Novavax shares had already doubled last Friday on this news, and over the past three months, t...
Alright, folks, let’s dive into the world of biotech drama. Shares of Novavax (NVAX) have been on a tear, continuing their climb on Monday after the company dropped some major news last week. They announced a licensing deal with Sanofi, and the stock shot up 47.6%, closing at $13.11. That's the highest it's been since December 2022.
But wait, there's more! Novavax shares had already doubled last Friday on this news, and over the past three months, t...
6
Meme stock volatility hit the market Monday, sending indexes higher, but shortly before noon EST, the market boomeranged back down. Just after the closing bell, the $标普500指数(.SPX.US$ had fallen flatly 0.02%, the $道琼斯指数(.DJI.US$ also declined 0.17%, and the $纳斯达克综合指数(.IXIC.US$ climbed 0.28%.
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
MACRO
This week, investors can expect macroeconomic data prints in the form of PPI on Tuesday, and CPI prints Wednesd...
+1
28
4
$诺瓦瓦克斯医药(NVAX.US$
👉 Key Highlights:
📍 Novavax's shares jump 120% in premarket trading after announcing a deal with Sanofi.
📍 Partnership to co-commercialize Covid vaccine and develop combination flu shots.
📍 Sanofi to make an upfront payment of $500 million to Novavax, with potential for up to $700 million more.
📍 Deal includes royalties and up to $200 million in additional milestones.
📍 Sanofi acquires less than ...
👉 Key Highlights:
📍 Novavax's shares jump 120% in premarket trading after announcing a deal with Sanofi.
📍 Partnership to co-commercialize Covid vaccine and develop combination flu shots.
📍 Sanofi to make an upfront payment of $500 million to Novavax, with potential for up to $700 million more.
📍 Deal includes royalties and up to $200 million in additional milestones.
📍 Sanofi acquires less than ...
3
3
Top 10 drug companies raked in NEARLY TRIPLE the revenue in 2023 ($491B) vs 2013 ($165B) 2013 vs. 2023.
$艾伯维公司(ABBV.US$ +189%
$施贵宝(BMY.US$ +175%
$强生(JNJ.US$ +95%
$阿斯利康(AZN.US$ +78%
$NVM +45%
$默沙东(MRK.US$ +37%
$罗氏(ADR)(RHHBY.US$ +27%
$辉瑞(PFE.US$ +13%
$葛兰素史克(GSK.US$ +13%
----- $SPDR 标普500指数ETF(SPY.US$ +12% -----
$赛诺菲安万特(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
$艾伯维公司(ABBV.US$ +189%
$施贵宝(BMY.US$ +175%
$强生(JNJ.US$ +95%
$阿斯利康(AZN.US$ +78%
$NVM +45%
$默沙东(MRK.US$ +37%
$罗氏(ADR)(RHHBY.US$ +27%
$辉瑞(PFE.US$ +13%
$葛兰素史克(GSK.US$ +13%
----- $SPDR 标普500指数ETF(SPY.US$ +12% -----
$赛诺菲安万特(SNY.US$ +3%
Source: Arjun Murthy on the HR app!
3
1
📌Last week’s PDUFAs:
$Heron Therapeutics(HRTX.US$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia(LQDA.US$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies(THTX.US$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$赛诺菲安万特(SNY.US$ & $再生元制药公司(REGN.US$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
$Heron Therapeutics(HRTX.US$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia(LQDA.US$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies(THTX.US$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$赛诺菲安万特(SNY.US$ & $再生元制药公司(REGN.US$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
12
1
阅读更多